Coya Therapeutics director files initial Form 3

Coya Therapeutics, Inc. filed an initial insider ownership report for director Mark H. Pavao on Form 3.

Accepted by SEC EDGAR 04/09/2026 - 06:42 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Coya Therapeutics, Inc. filed an initial insider ownership report for director Mark H. Pavao on Form 3. This filing establishes his status as a reporting person and provides a baseline for tracking any future changes in his ownership of Coya Therapeutics securities.

Key Terms

Form 3, reporting person, beneficial ownership

3 terms

Form 3 regulatory

"filed an initial insider ownership report for director Mark H. Pavao on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"establishes his status as a reporting person and provides a baseline"

beneficial ownership financial

"initial beneficial ownership report, creating a baseline before any future transactions"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing for COYA director Mark H. Pavao indicate?

The Form 3 shows that Mark H. Pavao is now an insider of Coya Therapeutics as a director. It serves as his initial beneficial ownership report, creating a baseline before any future transactions in Coya securities are disclosed.

Does the COYA Form 3 show any recent share purchases or sales?

No transactions are reported in this Form 3 for Coya Therapeutics. It is an initial ownership filing, meaning it simply registers the director as a reporting person rather than documenting any current buy or sell activity.

Why is a Form 3 important for Coya Therapeutics (COYA) investors?

Form 3 is important because it identifies new insiders at Coya Therapeutics who must report their holdings. Once filed, any future trades by this director must be disclosed on Forms 4 or 5, improving transparency around insider activity.

Does the COYA Form 3 disclose derivative securities or options for the director?

The Form 3 data provided does not list any derivative securities for the director. Both the transaction list and derivative summary are empty, indicating no options or similar instruments are being reported in this initial filing.

What ownership changes can future filings show for COYA’s director?

Future filings, typically Forms 4 or 5, can show the director’s purchases, sales, grants, or option exercises in Coya Therapeutics securities. This Form 3 simply establishes the starting point for tracking those potential ownership changes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pavao Mark H

(Last) (First) (Middle)

5850 SAN FELIPE ST., SUITE 500

(Street)

HOUSTON TEXAS 77057

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
Coya Therapeutics, Inc. [ COYA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24- Power of Attorney

No securities are beneficially owned.

	/s/ David Snyder, Attorney-in-Fact	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)